Calithera Biosciences, Inc. (NASDAQ:CALA – Get Free Report)’s share price passed above its 50-day moving average during trading on Tuesday . The stock has a 50-day moving average of $0.00 and traded as high as $0.00. Calithera Biosciences shares last traded at $0.00, with a volume of 10,853 shares trading hands.
Analyst Upgrades and Downgrades
Separately, StockNews.com assumed coverage on Calithera Biosciences in a research report on Wednesday. They set a “hold” rating on the stock.
View Our Latest Stock Report on Calithera Biosciences
Calithera Biosciences Price Performance
Calithera Biosciences Company Profile
Calithera Biosciences, Inc operates under a plan of liquidation that was approved in January 2023. Previously, the company was engaged in the clinical stage precision oncology biopharmaceutical business. Calithera Biosciences, Inc was incorporated in 2010 and is headquartered in South San Francisco, California.
Featured Articles
- Five stocks we like better than Calithera Biosciences
- How to Know Which Cryptocurrency to Buy: A Guide for Investors
- Tariff-Proof Stocks: 3 Big Bargains With Huge Upside Potential
- Growth Stocks: What They Are, What They Are Not
- Qualcomm Breaks Down But RSI Signals It’s Severely Oversold
- 3 Stocks to Protect Your Portfolio from the Coronavirus Contagion
- Tesla’s #1 Bull Cuts Target But Says It’s Still a Buy
Receive News & Ratings for Calithera Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Calithera Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.
